Pay in 4 interest-free payments of $7.35 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Retatrutide (Triple GLP-1/GIP/Glucagon Agonist) Research Peptide $ 189.00 $ 479.00Price range: $ 189.00 through $ 479.00 Retatrutide (GLP1 R) is a 39-amino-acid triple receptor agonist research peptide that activates GLP-1, GIP, and glucagon receptors simultaneously, studied for its role in multi-pathway incretin signaling and metabolic receptor interaction research
Cyanocobalamin is a manufactured form of B 12
GLP-1 Medication Support Anyone Can Get a GLP-1
Prevalence of normal Coronary Arteries by Coronary Computed Tomography Angiography (CCTA) in Patients with Type 2 Diabetes Mellitus from Semaglutide Treatment on Coronary Plaque Progression (STOP) Trial
An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice
Approved by the FDA in October 2006, and branded as Januvia, the drug soon became one of Merck's most successful drugs
US$ 22.74
US$ 26.78
US$ 22.63
US$ 28.22
